Wright Medical Group, Inc. Contingent Value Right
WMGIZ
WMGIZ was delisted on the 7th of March, 2019.
20 hedge funds and large institutions have $25.6M invested in Wright Medical Group, Inc. Contingent Value Right in 2018 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 7 increasing their positions, 0 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 20 → 20 (0)
9% less capital invested
Capital invested by funds: $28.1M → $25.6M (-$2.48M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NM
Newtyn Management
New York
|
+$139K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$37.5K |
| 3 |
Morgan Stanley
New York
|
+$6.83K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$6.6K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$2.15K |
Top Sellers
WMGIZ Hedge Fund Activity: Q1 2018 in Review
20 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in Wright Medical Group, Inc. Contingent Value Right (WMGIZ) for Q1 2018, worth a combined $25.6M — down 8.8% from $28.1M a quarter earlier.
Fund positioning in WMGIZ was balanced in Q1 2018: 0 funds opened new positions, 0 closed out, 7 added to existing stakes and 0 trimmed.
The largest buyer was Newtyn Management, adding an estimated $139K.
- 20 institutional investors held Wright Medical Group, Inc. Contingent Value Right (WMGIZ) as of Q1 2018, unchanged from Q4 2017.
- Funds reported $25.6M of Wright Medical Group, Inc. Contingent Value Right stock for Q1 2018, down 8.8% quarter-over-quarter.
- 0 funds opened new Wright Medical Group, Inc. Contingent Value Right positions in Q1 2018 and 0 closed out.
- The largest Wright Medical Group, Inc. Contingent Value Right buyer in Q1 2018 was Newtyn Management, an estimated $139K added.
Based on aggregated 13F filings for Q1 2018.